X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2244) 2244
Publication (228) 228
Book Chapter (15) 15
Magazine Article (7) 7
Book Review (6) 6
Web Resource (4) 4
Dissertation (2) 2
Book / eBook (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
zygomycosis (1648) 1648
humans (1436) 1436
mucormycosis (1012) 1012
index medicus (848) 848
male (847) 847
female (604) 604
antifungal agents - therapeutic use (542) 542
middle aged (507) 507
adult (480) 480
microbiology (416) 416
infectious diseases (401) 401
mycology (328) 328
mucormycosis - microbiology (302) 302
epidemiology (296) 296
mucormycosis - diagnosis (279) 279
amphotericin b - therapeutic use (277) 277
mucormycosis - drug therapy (273) 273
diagnosis (271) 271
aged (268) 268
infection (267) 267
zygomycosis - diagnosis (255) 255
zygomycosis - drug therapy (255) 255
infections (247) 247
immunocompromised host (243) 243
animals (242) 242
aspergillosis (238) 238
posaconazole (227) 227
health aspects (225) 225
amphotericin b (223) 223
child (219) 219
risk factors (219) 219
fungi (218) 218
immunology (212) 212
mycoses (212) 212
adolescent (207) 207
treatment outcome (201) 201
zygomycosis - microbiology (201) 201
amphotericin-b (193) 193
fatal outcome (192) 192
therapy (187) 187
transplantation (179) 179
voriconazole (179) 179
surgery (173) 173
fungal-infections (172) 172
mucormycosis - pathology (167) 167
dermatology (165) 165
fungal infections (163) 163
veterinary sciences (158) 158
rhizopus (157) 157
mortality (155) 155
zygomycosis - pathology (155) 155
care and treatment (149) 149
antifungal agents (144) 144
patient (144) 144
triazoles - therapeutic use (144) 144
mucormycosis - complications (140) 140
antifungal agents - administration & dosage (137) 137
disease (137) 137
young adult (135) 135
mucormycosis - etiology (126) 126
rhizopus - isolation & purification (126) 126
pathology (123) 123
mucorales - isolation & purification (120) 120
pharmacology & pharmacy (119) 119
rhinocerebral mucormycosis (118) 118
retrospective studies (117) 117
child, preschool (116) 116
diabetes (116) 116
pediatrics (113) 113
mucormycosis - therapy (108) 108
debridement (107) 107
diagnosis, differential (107) 107
mucorales (107) 107
leukemia (106) 106
management (106) 106
hematology (100) 100
amphotericin b - administration & dosage (99) 99
tomography, x-ray computed (94) 94
antifungal agents - pharmacology (93) 93
oncology (93) 93
zygomycosis - epidemiology (93) 93
zygomycosis - complications (89) 89
medicine, general & internal (88) 88
invasive fungal-infections (87) 87
liposomal amphotericin-b (87) 87
mucormycosis - epidemiology (87) 87
diabetes mellitus (86) 86
salvage therapy (86) 86
itraconazole (85) 85
mucormycosis - surgery (84) 84
identification (81) 81
infant (81) 81
antiparasitic agents (80) 80
pulmonary mucormycosis (80) 80
research (79) 79
case studies (77) 77
zygomycosis - therapy (77) 77
biopsy (76) 76
aspergillus (75) 75
mycoses - drug therapy (75) 75
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2013) 2013
French (76) 76
Spanish (63) 63
German (42) 42
Portuguese (24) 24
Japanese (23) 23
Chinese (4) 4
Dutch (4) 4
Italian (4) 4
Turkish (4) 4
Polish (3) 3
Danish (2) 2
Hungarian (2) 2
Korean (1) 1
Russian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Emerging Infectious Diseases, ISSN 1080-6040, 09/2009, Volume 15, Issue 9, pp. 1395 - 1401
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 6/2012, Volume 54, Issue 12, pp. 1685 - 1691
Journal Article
Journal Article
Clinical Microbiology and Infection, ISSN 1198-743X, 12/2011, Volume 17, Issue 12, pp. 1859 - 1867
Zygomycosis is an important emerging fungal infection, associated with high morbidity and mortality. The Working Group on Zygomycosis of the European... 
treatment | zygomycosis | Epidemiology | mucormycosis | Europe | Mucormycosis | Treatment | Zygomycosis | VORICONAZOLE | INFECTIOUS DISEASES | MICROBIOLOGY | INVASIVE FUNGAL-INFECTIONS | AMPHOTERICIN-B | IN-VITRO SUSCEPTIBILITIES | CELL TRANSPLANT RECIPIENTS | POSACONAZOLE PROPHYLAXIS | SURVEILLANCE NETWORK TRANSNET | BREAKTHROUGH ZYGOMYCOSIS | HEMATOLOGIC MALIGNANCIES | Age Distribution | Diabetes Complications | Prospective Studies | Fungi - classification | Humans | Middle Aged | Zygomycosis - mortality | Child, Preschool | Fungi - isolation & purification | Infant | Male | Young Adult | Hematopoietic Stem Cell Transplantation - adverse effects | Aged, 80 and over | Adult | Female | Hematologic Neoplasms - complications | Child | Risk Factors | Wounds and Injuries - complications | Europe - epidemiology | Zygomycosis - epidemiology | Adolescent | Survival Analysis | Sex Distribution | Aged | Antifungal Agents - administration & dosage | Amphotericin B | Analysis | Antiparasitic agents | Transplantation | Diabetes | Health aspects | Hematopoietic stem cells | Multivariate analysis | Medical research | Mortality | Cell culture | Diabetes mellitus | stem cell transplantation | Case reports | Malignancy | Regression analysis | Survival | Trauma | Morbidity | Soft tissues | Infection | Databases | Surgery | Caspofungin | Posaconazole | Age
Journal Article